Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a commercial biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for ...

"The best part of the job is hopefully curing somebody of cancer and giving them back the life they and their family wouldn’t ...